ArticleInternational journal of clinical pharmacy2025

Development of a machine learning-based risk prediction model and analysis of risk factors for docetaxel-induced bone marrow suppression in breast cancer patients.

Hongya Ou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.